We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+21.28%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.03B
AUM Growth
+$408M
(+25%)
Cap. Flow
+$76.6M
Cap. Flow
% of AUM
3.78%
Top 10 Holdings %
Top 10 Hldgs %
49.69%
Holding
77
New
15
Increased
27
Reduced
15
Closed
12
Top Buys
| 1 |
AstraZeneca
AZN
|
+$71M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$60.3M |
| 3 |
ALDR
Alder Biopharmaceuticals
ALDR
|
+$44.3M |
| 4 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
+$38.2M |
| 5 |
Insmed
INSM
|
+$37.7M |
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$66.3M |
| 2 |
Elevance Health
ELV
|
+$43.6M |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$35M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$32M |
| 5 |
Penumbra
PEN
|
+$31.5M |
Sector Composition
| 1 | Healthcare | 89.36% |
| 2 | Financials | 3.41% |
| 3 | Communication Services | 0.62% |
| 4 | Energy | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $216M | 10.65% |
17,556,586
+1,462,800
| +9% | +$13.6M |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $166M | 8.19% |
11,012,561
-1,031,371
| -9% | -$13.6M |
|
3
Puma Biotechnology
PBYI
$428M
| $109M | 5.36% |
906,642
+46,186
| +5% | +$4.3M |
|
|
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
| $100M | 4.95% |
1,843,733
+1,178,594
| +177% | +$60.3M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $82.1M | 4.05% |
996,610
+232,221
| +30% | +$18.4M |
|
|
ALDR
6
DELISTED
Alder Biopharmaceuticals
ALDR
| $79.3M | 3.91% |
6,476,766
+4,252,955
| +191% | +$44.3M |
|
|
7
AstraZeneca
AZN
$261B
| $76.1M | 3.75% |
+1,123,150
| New | +$71M |
|
|
8
Insmed
INSM
$23.8B
| $62.2M | 3.07% |
1,991,646
+1,979,266
| +15,988% | +$37.7M |
|
|
IMGN
9
DELISTED
Immunogen Inc
IMGN
| $61.7M | 3.04% |
8,061,497
+2,848,761
| +55% | +$18.9M |
|
10
Regenxbio
RGNX
$634M
| $55M | 2.71% |
1,667,672
-50,999
| -3% | -$1.15M |
|
|
11
Penumbra
PEN
$12.5B
| $51.1M | 2.52% |
565,511
-365,933
| -39% | -$31.5M |
|
12
Wave Life Sciences
WVE
$1.14B
| $49.3M | 2.43% |
2,267,707
+43,300
| +2% | +$870K |
|
13
Atara Biotherapeutics
ATRA
$77M
| $47.8M | 2.36% |
115,588
+6,226
| +6% | +$2.35M |
|
14
LivaNova
LIVN
$4.36B
| $44.3M | 2.19% |
632,488
+420,460
| +198% | +$26.6M |
|
15
Centene
CNC
$32.9B
| $39.2M | 1.93% |
809,200
+12,800
| +2% | +$551K |
|
16
ICU Medical
ICUI
$3.95B
| $37.5M | 1.85% |
201,750
+69,245
| +52% | +$12.1M |
|
|
AET
17
DELISTED
Aetna Inc
AET
| $37.2M | 1.83% |
+233,837
| New | +$36.5M |
|
|
BOLD
18
DELISTED
Audentes Therapeutics, Inc
BOLD
| $36.1M | 1.78% |
1,289,332
-170,284
| -12% | -$3.7M |
|
|
OXFD
19
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $34.5M | 1.7% |
2,051,487
-104,462
| -5% | -$1.7M |
|
|
GWPH
20
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $34.4M | 1.69% |
338,536
-106,400
| -24% | -$11.4M |
|
21
eHealth
EHTH
$48.6M
| $32M | 1.58% |
1,337,623
+114,289
| +9% | +$2.33M |
|
22
Molina Healthcare
MOH
$12.2B
| $31.7M | 1.56% |
461,074
-367,500
| -44% | -$23.9M |
|
|
PRAH
23
DELISTED
PRA Health Sciences, Inc.
PRAH
| $30.6M | 1.51% |
+402,014
| New | +$30.4M |
|
|
ELGX
24
DELISTED
Endologix Inc
ELGX
| $29.2M | 1.44% |
654,468
+17,638
| +3% | +$804K |
|
|
NITE
25
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $28.8M | 1.42% |
+1,769,346
| New | +$38.2M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO